Springworks Therapeutics Inc (SWTX) Inventory Turnover Ratio, from first quarter 2025 to first quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Springworks Therapeutics Inc   (NASDAQ: SWTX)
 

Springworks Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2025, Springworks Therapeutics Inc 's inventory turnover ratio sequentially decreased to 1.48 in the first quarter 2025, otherwise the ratio remained above the average, as SWTX's markets remain strong.Springworks Therapeutics Inc 's average inventory processing period in the Mar 31 2025 quarter, has increased to 247 days, from 240 days, in the Dec 31 2024 quarter.

Within Healthcare sector 279 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2025, to 1028, from total ranking in the fourth quarter 2024 at 1079.

SWTX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Springworks Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SWTX Inventory Turnover Ratio (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Inventory Growth 138.06 % 229.1 % - - -
Y / Y Cost of Sales Growth 193.43 % 1216.11 % - - -
Inventory Turnover Ratio (TTM) 1.48 1.52 1.15 1.02 0.78
SWTX's Total Ranking # 1028 # 1079 # 1659 # 0 # 0
Average inventory processing period 246 240 318 359 467
Seq. Inventory Growth 21.59 % 3.93 % 27.31 % 47.97 % 68.1 %
Seq. Cost of Sales Growth -36.5 % 66.24 % 36.2 % 104.08 % 184.83 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 20
Healthcare Sector # 280
Overall Market # 1028

Inventory Turnover Ratio Statistics
High Average Low
1.52 1.38 1.15
(Dec 31 2024)   (Sep 30 2024)



SWTX Company Profile >> Back to SWTX Efficiency Comparisons >> Compare SWTX Inventory Turnover Ratio to its Competitors

Financial Statements
Springworks Therapeutics Inc 's Inventories $ 12 Millions Visit SWTX's Balance sheet
Springworks Therapeutics Inc 's Cost of Revenues TTM $ 15 Millions Visit SWTX's Income Statement
What are SWTX's Sales? Visit SWTX's Sales by Segment

Other Inventory Turnover Ratios
Springworks Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SWTX's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SWTX's Competitors
Inventory Turnover Ratio for SWTX's Suppliers
Inventory Turnover Ratio for SWTX's Customers

You may also want to know
SWTX's Sales Growth Rates SWTX's Pe Price to earnings ratio SWTX's Receivables Turnover Ratio SWTX's Stock Quote
SWTX's Net Income Growth Rates SWTX's Ps Price to Sales ratio SWTX's Sales per Employee SWTX's Asset Turnover Ratio
SWTX's Net Margin SWTX's Pb Price to Book ratio SWTX's Financial Strength Ratios SWTX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2025 Inventories at quarter ending Mar 31 2025
Baxter International Inc   3.27 $ 7,605.000  Millions$ 2,326  Millions
Inmed Pharmaceuticals Inc  3.23 $ 3.534  Millions$ 1  Millions
Ardelyx inc   3.18 $ 55.731  Millions$ 18  Millions
Sonoma Pharmaceuticals Inc   3.17 $ 8.823  Millions$ 3  Millions
Agilent Technologies inc   3.16 $ 3,092.000  Millions$ 978  Millions
Becton Dickinson And Company  3.16 $ 11,581.000  Millions$ 3,666  Millions
Tandem Diabetes Care Inc   3.10 $ 469.000  Millions$ 151  Millions
Maravai Lifesciences Holdings Inc   3.04 $ 151.666  Millions$ 50  Millions
Mettler toledo International Inc   3.02 $ 1,088.733  Millions$ 361  Millions
Elite Pharmaceuticals Inc   3.01 $ 43.000  Millions$ 14  Millions
Dexcom Inc   3.01 $ 1,682.000  Millions$ 559  Millions
Amneal Pharmaceuticals Inc   3.00 $ 1,790.478  Millions$ 596  Millions
Msa Safety Inc  3.00 $ 957.000  Millions$ 319  Millions
Dentsply Sirona Inc   3.00 $ 1,801.000  Millions$ 601  Millions
International Stem Cell Corporation  2.97 $ 3.869  Millions$ 1  Millions
Akebia Therapeutics Inc   2.95 $ 59.197  Millions$ 20  Millions
Nexgel Inc   2.94 $ 5.011  Millions$ 2  Millions
Brightspring Health Services Inc   2.94 $ 1,488.101  Millions$ 507  Millions
Tvardi Therapeutics Inc   2.91 $ 2.963  Millions$ 1  Millions
Lucid Diagnostics Inc   2.87 $ 1.551  Millions$ 1  Millions
Bausch Health Companies Inc   2.87 $ 2,784.000  Millions$ 972  Millions
Tenon Medical Inc   2.83 $ 1.720  Millions$ 1  Millions
Abbott Laboratories  2.83 $ 18,711.000  Millions$ 6,615  Millions
Caredx Inc   2.82 $ 57.092  Millions$ 20  Millions
Cytosorbents Corporation  2.70 $ 9.000  Millions$ 3  Millions
Liquidia Corporation  2.68 $ 5.929  Millions$ 2  Millions
Lftd Partners Inc   2.67 $ 24.194  Millions$ 9  Millions
Revvity Inc  2.67 $ 1,036.092  Millions$ 389  Millions
Immucell Corporation  2.64 $ 19.265  Millions$ 7  Millions
Mimedx Group Inc   2.63 $ 64.000  Millions$ 24  Millions

Date modified: 2026-09-02T08:18:52+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.